References

Global, Regional, and National Incidence and Mortality Burden of non‐COVID‐19 Lower Respiratory Infections and Aetiologies, 1990–2021: A Systematic Analysis From the Global Burden of Disease Study 2021

10.1016/s1473-3099(24)00176-2 · 2024 · External reference

A Review of Vaccine Research and Development: Human Acute Respiratory Infections

10.1016/j.vaccine.2005.07.046 · 2005 · External reference

Community‐Acquired Pneumonia Requiring Hospitalization Among Us Adults

10.1056/nejmoa1500245 · 2015 · External reference

Characteristics of SARS‐CoV‐2 and COVID‐19

10.1038/s41579-020-00459-7 · 2021 · External reference

A Pneumonia Outbreak Associated With a New Coronavirus of Probable Bat Origin

10.1038/s41586-020-2012-7 · 2020 · External reference

Global, Regional, and National Disease Burden Estimates of Acute Lower Respiratory Infections Due to Respiratory Syncytial Virus in Children Younger Than 5 Years in 2019: a Systematic Analysis

10.1016/s0140-6736(22)00478-0 · 2022 · External reference

Estimates of Global Seasonal Influenza‐Associated Respiratory Mortality: A Modelling Study

10.1016/s0140-6736(17)33293-2 · 2018 · External reference

Respiratory Virus Infections: Understanding COVID‐19

10.1016/j.immuni.2020.05.004 · 2020 · External reference

Anti‐Influenza T Cells in Bronchoalveolar Microenvironment of Critically Severe COVID‐19 Patients

10.1186/s13054-021-03871-4 · 2021 · External reference

Editor Clinical Significance of Viral Sociology Emerges as Influenza Season Collides With COVID‐19 Pandemic

10.1016/j.mayocp.2023.08.024 · 2023 · External reference

Burden of Acute Respiratory Infections Caused by Influenza Virus, Respiratory Syncytial Virus, and SARS‐CoV‐2 With Consideration of Older Adults: A Narrative Review

10.1007/s40121-024-01080-4 · 2025 · External reference

SARS‐CoV‐2 Co‐Infection With Influenza Viruses, Respiratory Syncytial Virus, or Adenoviruses

10.1016/s0140-6736(22)00383-x · 2022 · External reference

COVID‐19, Influenza and Rsv: Surveillance‐Informed Prevention and Treatment–Meeting Report From an isirv‐WHO Virtual Conference

10.1016/j.antiviral.2021.105227 · 2022 · External reference

Guidelines for Reporting of Statistics for Clinical Research in Urology

10.1097/ju.0000000000000001 · 2019 · External reference

COVID‐19 and Respiratory Virus Co‐Infections: A Systematic Review of the Literature

10.3390/v15040865 · 2023 · External reference

COVID‐19 and Influenza Co‐Infection: A Systematic Review and Meta‐Analysis

10.3389/fmed.2021.681469 · 2021 · External reference

Co‐Infection in Critically Ill Patients With COVID‐19: An Observational Cohort Study From England

10.1099/jmm.0.001350 · 2021 · External reference

Coinfection of SARS‐CoV‐2 With Other Respiratory Pathogens in Outpatients From Ecuador

10.3389/fpubh.2023.1264632 · 2023 · External reference

Decreased Influenza Activity During the Covid‐19 Pandemic—United States, Australia, Chile, and South Africa, 2020

10.15585/mmwr.mm6937a6 · 2020 · External reference

Unresolved reference

2022 · External reference

Co‐Infections in People With COVID‐19: A Systematic Review and Meta‐Analysis

10.1016/j.jinf.2020.05.046 · 2020 · External reference

Prevalence and Outcomes of Co‐Infection and Superinfection With SARS‐CoV‐2 and Other Pathogens: A Systematic Review and Meta‐Analysis

10.1371/journal.pone.0251170 · 2021 · External reference

SARS‐CoV‐2, Influenza A/B and Respiratory Syncytial Virus Positivity and Association With Influenza‐Like Illness and Self‐Reported Symptoms, Over the 2022/23 Winter Season in the UK: A Longitudinal Surveillance Cohort

10.1186/s12916-024-03351-w · 2024 · External reference

Malveste Ito CR, Moreira ALE, Silva PANd, Santos MDO, Santos APd, Rézio GS Viral Coinfection of Children Hospitalized With Severe Acute Respiratory Infections During COVID‐19 Pandemic

10.3390/biomedicines11051402 · 2023 · External reference